360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Purdue Pharma L.P.

Type: Company

Name: Purdue Pharma L.P. (Purdue Pharma L.P)

Nationality: United States

Fact Sheet: Fact Sheet for Purdue Pharma L.P.

First reported 8 hours ago - Updated 8 hours ago - 1 reports

Pharma Industry Gets Tough On Cargo Theft

Improved technology, monitoring, legal changes and industry efforts to secure supply chains have made a sizable impact on reducing theft of pharmaceutical products, Purdue Pharma’s Charles Forsaith says. ... [Published The Rose Sheet - 8 hours ago]

Entities: Theft, Purdue Pharma L.P.

First reported 9 hours ago - Updated 9 hours ago - 1 reports

Court Report -- May 19, 2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.• Plaintiff: AbbVie Inc.• Defendants: Hetero USA Inc.; Hetero Labs Ltd.Infringement of U.S. Patent Nos. 7,148,359 ("Polymorph of a Pharmaceutical," issued ... [Published JD Supra - 9 hours ago]

Entities: Endo Pharmaceuticals Holdings Incorporated, Generic Version, Par Pharmaceutical, Par Pharmaceutical Companies Inc, Infringement

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Purdue puts Intermezzo DTC to bed

Purdue Pharma is slashing the marketing push behind the Transcept-Purdue sleep drug Intermezzo, two years after FDA approval and six months after launching a $29 million campaign to elevate the drug's profile. Transcept Pharmaceuticals announced in an ... [Published Medical Marketing And Media - May 16 2013]

Entities: Drugs, FDA Food & Drug Administration, Transcept Pharmaceuticals

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Eli Lilly & Company

Cheerleaders: Look Beyond Pharma For Jobs

Amid the tumult that is the drug industry, have long since become commonplace. And keeping tabs can be quite an exercise, but here are two of the latest examples. Purdue Pharma is scrapping 90 contract who sold the Intermezzo sleeping pill, which is made ... [Published Yahoo! Finance - May 16 2013]

Entities: Eli Lilly & Company, Pfizer Inc, Transcept Pharmaceuticals, Drugs, Purdue Pharma L.P.

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Parties settle in Stamford murder case

STAMFORD -- The family of the woman stabbed and bludgeoned to death at the hands of a romantic rival in 2002 has settled a lawsuit filed against the Shippan condominium complex where she lived for an undisclosed sum.Attorney Louis Chimes of Stamford said ... [Published News-Times - May 16 2013]

Entities: Homicide, Purdue Pharma L.P., Michael Ryan, Civil Case

First reported May 15 2013 - Updated May 15 2013 - 2 reports

Office of Criminal Investigations

Hooked On Legal Drugs

Ann Silversides explores opioid abuse in Canada and the US, and the failure of drug companies and government in curtailing abuse:When OxyContin was approved—1995 in the United States, the following year in Canada—Purdue Pharma began to aggressively market ... [Published Atlantic Monthly - May 15 2013]

Entities: Drugs, OxyContin, Overdose, Office of Criminal Investigations, Abuse

First reported May 14 2013 - Updated May 14 2013 - 1 reports

FDA Food & Drug Administration

Attorneys General Ask FDA to Require Warning for Drugs

The National Association of Attorneys General has asked the U.S. Food and Drug Administration to place a “black box warning” on labels of the opioid category of prescription-pain relievers to alert pregnant women that use of such drugs may harm infan ... [Published Bloomberg - May 14 2013]

Entities: opioid, FDA Food & Drug Administration, NAS

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Endo hit hard by FDA's refusal to reject generics

Endo's stock fell 5 percent Friday, then 3.6 percent more Monday, closing at $33.71.vern-based Endo Health Solutions Inc. dealt Monday with the fallout from an adverse decision Friday by the Food and Drug Administration, which rejected Endo's complicated ... [Published Philly.com - May 14 2013]

Entities: FDA Food & Drug Administration, Opana ER, opioid, anodyne

First reported May 13 2013 - Updated May 13 2013 - 2 reports

How Do You Make A Painkiller Addiction-Proof?

In 2010, OxyContin introduced a new formula that drug abusers can't crush to a powder to snort or inject. This is how it works, chemically, and whether it actually deters abuse.For those who have severe chronic pain, the advantage of OxyContin over other ... [Published Popular Science - May 13 2013]

Entities: OxyContin, Abuse, opioid

First reported May 10 2013 - Updated May 11 2013 - 3 reports

FDA Rules to Continue Sales of Generic Opana Painkiller

Federal regulators announced on Friday that the sales of generic Opana will be continued even though the pills are prone to abuse. The narcotic painkiller is similar to OxyContin.The drug is developed to offer pain relief for several hours. These are ... [Published French Tribune - May 11 2013]

Entities: OxyContin, Opana ER, Endo Pharmaceuticals Holdings Incorporated

First reported May 06 2013 - Updated May 06 2013 - 2 reports

Many Drug Companies Creating Abuse-Resistant Painkillers

scription Drugs & PreventionMore than a dozen drug companies are working on abuse-resistant painkillers, in the wake of the Food and Drug Administration’s (FDA) decision last month not to approve any generic versions of the original form of OxyContin ... [Published Join Together - May 06 2013]

Entities: Drugs, OxyContin, Purdue Pharma L.P., FDA Food & Drug Administration, anodyne

First reported May 01 2013 - Updated May 01 2013 - 2 reports

OxyContin And The Art Of 'Evergreening'

A few weeks back, we wrote about the Indian Supreme Court's rejection of Novartis's attempt to use "evergreening" to prolong its patent on Gleevec, sold as Glivec in India. That term refers to the trick of making small changes to a drug, usually one about ... [Published PharmaGossip - May 01 2013]

Entities: OxyContin, Patent, Purdue Pharma L.P.

Quotes

"The family is very happy with closure. I can't say what the settlement is because it is confidential," said Chimes. "Whatever they have received from the settlement will go to a fund they established in their daughter's memory for a student to study medicine in the Philippines."

Parties settle in Stamford murder case [Published News-Times - May 16 2013]

"Based on these 2 recent decisions, we sense that FDA is setting a standard for how much effectiveness is required from the various tamper-proof mechanisms in order to delay the launch of generic alternatives,” Cynthia Ambres, MD, partner, US member of KPMG’s Global Healthcare Center of Excellence, told Formulary."

FDA denies request to block generic versions of Opana ER [Published Formulary Journal - May 15 2013]

"As the use of prescription opioid analgesics increases, so do the instances of NAS," wrote the Attorneys General in their letter to the FDA. "We therefore believe that a black-box warning for these medications would help ensure that women of childbearing age, as well as their healthcare providers, are aware of the serious risks associated with narcotic use during pregnancy."

Attorney General Conway and Colleagues Urge FDA to Place Black Box Warning on Opioids [Published Pharmacy Choice - May 14 2013]

"I am very pleased to be joining Locust Walk Partners at this inflection point in its lifecycle," commented Mr. Ehrlich. "The firm has built a high quality reputation for and demonstrated a track record of success in executing high value strategic transactions. It is an ideal platform from which to help companies achieve their business and corporate development objectives."

Locust Walk Partners Announces Appointment of Chris Ehrlich, Biotechnology Industry and Venture Capi [Published Interest!ALERT - May 14 2013]

More Content

sort by: Date \| Relevance
Pharma Industry Gets Tough On Cargo Theft [Published The Rose Sheet - 8 hours ago]
Court Report -- May 19, 2013 [Published JD Supra - 9 hours ago]
Purdue puts Intermezzo DTC to bed [Published Medical Marketing And Media - May 16 2013]
Cheerleaders: Look Beyond Pharma For Jobs [Published Yahoo! Finance - May 16 2013]
Parties settle in Stamford murder case [Published News-Times - May 16 2013]
Hooked On Legal Drugs [Published Atlantic Monthly - May 15 2013]
Hooked On Legal Drugs [Published The Daily Dish \| By Andrew Sullivan - May 15 2013]
Locust Walk Partners Appoints MD [Published PE Hub News - May 15 2013]
FDA denies request to block generic versions of... [Published Formulary Journal - May 15 2013]
Endo’s petition to block generic forms of Opana... [Published Drugtopics.com - May 14 2013]
Attorney General Conway and Colleagues Urge FDA... [Published Pharmacy Choice - May 14 2013]
Locust Walk Partners Announces Appointment of C... [Published Interest!ALERT - May 14 2013]
Locust Walk Partners Announces Appointment of C... [Published ADVFN UK - May 14 2013]
Endo hit hard by FDA's refusal to reject generics [Published Philly.com - May 14 2013]
Attorneys General Ask FDA to Require Warning fo... [Published Bloomberg - May 14 2013]
Bad night: Purdue Pharma axes 90 reps of Transc... [Published San Francisco Business Times - May 13 2013]
FDA Denies Request from Opana ER Maker to Block... [Published Join Together - May 13 2013]
How Do You Make A Painkiller Addiction-Proof? [Published Popular Science - May 13 2013]
FDA move gives Purdue edge in painkiller market [Published Medical Marketing And Media - May 13 2013]
How Do You Make A Painkiller Addiction-Proof? [Published Popular Science - New Technology, Science News, ... - May 13 2013]
Johnson & Johnson: An Investment In A Healthcar... [Published Seeking Alpha - May 13 2013]
Infinity Releases 1Q 2013 Financial Results, Pr... [Published Individual.com - May 13 2013]
Generic version of narcotic Opana still for sal... [Published Individual.com - May 11 2013]
FDA Rules to Continue Sales of Generic Opana Pa... [Published French Tribune - May 11 2013]
FDA allows sales of generic Opana painkiller to... [Published Los Angeles Times - May 11 2013]
F.D.A. Rejects Request to Block Sales of Generi... [Published New York Times - May 11 2013]
FDA Rejects Endo Petition To Protect Its Opana ... [Published Forbes.com - May 10 2013]
Endo Loses Bid to Thwart Generic Versions of Op... [Published Washington Post - May 10 2013]
FDA denies request to block generic painkiller [Published Huffington Post - May 10 2013]
Endo Loses Bid to Stop Sales of Generic Painkil... [Published Bloomberg - May 10 2013]

Blogs

sort by: Date \| Relevance
Hooked On Legal Drugs [Published The Daily Dish \| By Andrew Sullivan - May 15 2013] Ann Silversides explores opioid abuse in Canada and the US, and the failure of drug companies and government in curtailing abuse: When OxyContin was approved—1995 in the United States, the following year in Canada—Purdue Pharma began to aggressively ...
DILAUDID (Hydromorphone Hydrochloride) Liquid D... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013] Updated Date: May 3, 2013 EST ...
DILAUDID (Hydromorphone Hydrochloride) Liquid D... [Published DailyMed Drug Label Updates for the last seven ... - May 03 2013] Updated Date: May 3, 2013 EST ...
OxyContin And The Art Of 'Evergreening' [Published PharmaGossip - May 01 2013] A few weeks back, we wrote about the Indian Supreme Court's rejection of Novartis's attempt to use "evergreening" to prolong its patent on Gleevec, sold as Glivec in India. That term refers to the trick of making small changes to a drug, usually one about ...
OxyContin And The Art Of 'Evergreening' [Published Techdirt - May 01 2013] A few weeks back, we wrote about the Indian Supreme Court's rejection of Novartis's attempt to use "evergreening" to prolong its patent on Gleevec, sold as Glivec in India. That term refers to the trick of making small changes to a drug, usually one about ...

Press Releases

sort by: Date \| Relevance
Purdue Pharma L.P. Announces Resolution of OxyC... [Published PR Newswire: Financial Services - Apr 26 2013]
Actavis Announces OxyContin® Patent Challenge S... [Published PR Newswire: Policy & Public Interest - Apr 26 2013]
Infinity Announces Closing of Secondary Offerin... [Published Business Wire - Apr 16 2013]
Infinity Announces Closing of Secondary Offerin... [Published Business Wire Health News - Apr 16 2013]
Infinity Announces Pricing of Secondary Offerin... [Published Business Wire Health News - Apr 11 2013]